Aptamer Group PLC (AIM:APTA)
London · Delayed Price · Currency is GBP · Price in GBX 0.8914
-0.0336 (-3.63%)
Feb 12, 2026, 3:10 PM GMT
Aptamer Group Market Cap
Aptamer Group has a market cap or net worth of 23.6 million as of February 12, 2026. Its market cap has increased by 178.84% in one year.
Market Cap
23.60M
Enterprise Value
23.03M
Revenue
1.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.89
Market Cap Chart
Since December 22, 2021, Aptamer Group's market cap has decreased from 97.55M to 23.60M, a decrease of -75.81%. That is a compound annual growth rate of -28.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 23.60M | -18.60% |
| Dec 31, 2025 | 28.99M | 308.04% |
| Dec 31, 2024 | 7.11M | 32.20% |
| Dec 29, 2023 | 5.37M | -84.73% |
| Dec 30, 2022 | 35.20M | -62.04% |
| Dec 31, 2021 | 92.73M | -4.95% |
| Dec 22, 2021 | 97.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hemogenyx Pharmaceuticals | 55.28M |
| SkinBioTherapeutics | 51.13M |
| hVIVO | 41.16M |
| Ondine Biomedical | 41.09M |
| Poolbeg Pharma | 32.43M |
| ImmuPharma | 32.38M |
| Arecor Therapeutics | 28.70M |
| Sareum Holdings | 23.47M |